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Background: Traditional healers have used plants to prevent or treat infectious diseases since time immemorial. 
Natural products of plant origin are therefore a potential source of novel antimicrobial agents. 
Objective: The objective of this study was to establish the antimicrobial properties of three selected medicinal plants 
as a basis for further research and possible development of herbal antimicrobial products.  
Methods: Methanolic and Ethylacetate extracts prepared from different parts of three medicinal plant species - 
Fuerstia africana, Pentas lanceolata and Sericocomposis hildebrandtii - were screened for antibacterial and antifungal 
activities using the agar well diffusion method at a concentration of 100mg/ml. The Minimum Inhibitory 
Concentration (MIC) values were determined for Fuerstia africana extracts. Gentamycin sulphate (0.1 µg/ml) and 
nystatin (0.1 µg/ml) were used as reference drugs for antibacterial and antifungal activities, respectively. 
Results: All the extracts tested exhibited antimicrobial activity with methanolic extracts of the aerial parts of Fuerstia 
africana and ethylacetate extracts of Pentas lanceolata roots showing the highest activity against Klebsiella pneumonia, 
with an inhibition zone measuring more than 17mm.  
Discussion: These results partially support the reported traditional medicinal use of these plants and shows that they 
are potential sources of new antimicrobial agents.  
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1. Introduction 
In recent years, drug resistance to human pathogenic 
bacteria and fungi has increasingly been reported all 
over the world (Levy and Marshall, 2004; WHO 2004). 
Consequently, the increasing prevalence of multidrug- 
resistant strains of microorganisms raises an urgent 
need to search for new sources of antimicrobial agents 
(Sieradzki et al, 1999) alongside other strategies such as 
regulated and rational use of antibiotics (Hernandez, 
2005). 
In Africa, traditional healers have for centuries been the 
main providers of primary health care (Scheinman, 
2002), extensively using herbal preparations in their 
practice. Plants are rich in a wide variety of secondary 
metabolites such as tannins, terpenoids, alkaloids, and 
flavonoids, many of which have been found to exhibit in 
vitro antimicrobial properties (Cowan, 1999; Lewis and 
Ausubel, 2006). Similarly, a number of Kenyan 
medicinal plants have been shown to possess 
antimicrobial properties (Matu and van Staden, 2003; 
Bii et al, 2008; Kareru et al, 2008).  
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The vast majority of traditionally used medicinal plants 
have not been adequately evaluated.  This study was 
therefore undertaken to screen organic extracts 
obtained from three Kenyan medicinal plants for 
antibacterial and antifungal activity as a basis for 
further phytochemical studies. The plants to be studied 
were selected on the basis of ethnopharmacological 
reports of their use in traditional medicine; this 
approach is generally considered effective in the 
discovery of new bioactive agents from higher plants 
(Kloucek et al, 2005). 
Pentas lanceolata (Forssk.) Defleurs belongs to the 
family Rubiaceae. A decoction of the roots or leaves is 
used topically or taken orally to treat lymphadenitis or 
boils (Giday et al, 2009). An infusion of the leaves of 
Fuerstia africana  T.C.E. Fr (Lamiaceae) is used to treat 
genital and oral thrush (TICHA 2008) while 
Sericocomposis  hildebrandtii Schinz (Amaranthaceae) 
roots juice is drunk for purgative effect and to treat 
dysmenorrhea (Kokwaro, 1993).  
 
2. Materials and Methods 
2.1 Collection of plant materials 
Plant materials (fresh roots and aerial parts) were 
collected from natural populations of the plants around 
Magadi, Kajiado District of Kenya in 2007.  
Authentication was carried out at the Department of 
Botany Herbarium, School of Biological Sciences, 
University of Nairobi, where voucher specimens were 
deposited. The voucher specimen numbers were 
assigned as follows: Fuerstia africana T.C.E. Friers 
(Lamiaceae): PGK 2007/1; Pentas lanceolata (Forssk.) 
Defleurs (Rubiceae): PGK 2007/2 ; Sericocomposis 
hildebrandtii Schinz (Amaranthaceae): PGK 2007/3. 
2.2 Preparation of extracts 
The plant materials were transported to Kenya Medical 
Research Institute (KEMRI) laboratories and washed 
thoroughly with running tap water, chopped into small 
pieces and then dried under shade for a period of 14 
days. The dried plant materials were then ground into 
fine powders using a laboratory grinding mill. The 
powders were placed in sealed airtight bags, well 
labelled and stored in the dark at room temperature 
until extraction. 
Fifty grams of the powdered material was then soaked 
in 500ml of ethyl acetate or methanol, macerated for 24 
hr and then filtered using Whatman No.1 filter paper. 
The filtrates were then dried under reduced pressure 
using a rotatory evaporator, yielding sticky brown 
residues that were further dried under a stream of 
nitrogen for 24 hr and used for the biological assays.  
For the antimicrobial assay, the extracts were 
reconstituted using DMSO to give a concentration of 
100mg/ml which was the test concentration.  
2.3 Test microorganisms and culture media 
The following microbial strains were used as test 
cultures: Eschericia coli ATCC 25922, Staphylococcus 
aureus, ATCC 29737, Klebsiella pneumonia, ATCC 15380, 
Bacillus subtilis, ATCC 441, Bacillus pumillus, ATCC 
14884 and a fungal strain, Candida albicans ATCC 
53324. The cultures were obtained from the National 
Quality Control Laboratory, Ministry of Health, Nairobi, 
Kenya. Tryptone soy agar and Sabourauds Dextrose 
agar (Oxoid, Hampshire, England) were used as nutrient 
media for the growth of bacteria and fungi respectively. 
2.4 Sterilization 
All the glassware used in the antimicrobial activity 
studies was sterilized in a Memmert Universal oven 
(Memmet GmbH and Co, KG, Schwabach, Germany) 
using dry heat at 150˚ C for I hr while the nutrient 
media and distilled water were sterilized using a 
portable autoclave (Dixons surgical Instruments Ltd, 
Sussex, UK) at 121˚ C for 15 min before use. The 
bacteriological wire loop and cork borer were sterilised 
by flaming using a Bunsen burner flame. All bench work 
involving use of micro-organisms was carried out in a 
Bioflow laminar flow cabinet (Vermeulen, L.J. BVBA, 
Westmalle, Belgium) while a Freezer-1 incubator 
(Analis, Suarlee, Belgium) was used for incubation of 
the micro-organisms. 
2.5 Antimicrobial assay 
Antimicrobial activity was determined using the agar 
diffusion method (Rojas et al, 2006). The test 
microorganisms were sub-cultured for 18h in their 
prescribed nutrient media to obtain working cultures. 
Nutrient media for growth of the test microorganisms 
were prepared as per the manufacturer’s instructions, 
sterilized and left to cool to around 50˚C. Each of the 
cultured microorganisms were suspended in 5 ml 
sterilized distilled water and the suspension inoculated 
into the respective growth medium so as to produce 
inoculated agar with about 106 colony forming units/ml. 
The inoculated nutrient media were then rapidly but 
carefully poured into 90mm Petri dishes using a 100ml 
measuring cylinder in such a manner as to deliver 20ml 
of the seeded agar with a uniform thickness of 3mm in 
each Petri dish. The seeded agar was allowed to cool so 
as to set into a firm gel.  
Using a symmetric paper template with 6 circles drawn 
in a hexagonal array, six cylindrical wells were punched 
in the seeded media using a cork borer (7mm, 
diameter). The test solutions of the extracts were 
applied into the wells using a fixed-volume 
micropipette set to deliver 50 µl per well. A pre-
diffusion period of 1 hr was allowed to facilitate 
diffusion of the applied solutions into the inoculated 
media before the Petri dishes were incubated for 18 hr 
at 37 °C for bacterial stains and 35 °C for Candida 
albicans.  Gentamycin sulphate (0.1 µg/ml) and Nystatin 
(0.1 µg/ml) were used as the standard reference drugs 
for antibacterial and antifungal activities respectively 
(Hewitt and Vincent, 1989). Negative controls 
comprised of 50 µl DMSO per well. 
Antimicrobial activity was estimated by measuring the 
zones of growth inhibition (clear zone) surrounding the 
wells. Diameters of the zones of inhibition were 
measured using a hand-held electronic digital Vernier 
Caliper with a precision of 0.1 mm. All tests were 
replicated three times and the results are given as the 
means and standard error of the means (SEM) of the 
Matu et al. Afr. J. Pharmacol. Ther. 2012. 1(1): 14-18 
 
A KeSoBAP Publication ©2012. All rights reserved. 
16 
diameters of the zones of growth inhibition. An 
inhibition zone of 14 mm or greater (including the 
diameter of the well) was considered as high 
antimicrobial activity (Phillip et al, 2009).   
F. africana extracts were also evaluated to determine 
the Minimum Inhibitory Concentration (MIC) using the 
agar well diffusion technique. Serial dilutions of the test 
extracts were prepared in DMSO to yield solutions of 
50, 25, 12.5, 6.25, 3.12, 1.56, 0.78 and 0.39 mg/ml. Fifty 
µl aliquots of each dilution were introduced into wells 
in nutrient agar plates already seeded with the 
standardised inoculums of Staphylococcus aureus 
(Gram-Positive bacterial strain), Eschericia coli (Gram-
negative bacteria strain) and Candida albicans (a fungi). 
The test plates were incubated under the same 
condition as the screening stage. The lowest 
concentration of each extract showing a clear zone of 
inhibition was taken as the MIC. 
3. Results 
The antimicrobial effects of the tested organic extracts 
at a concentration of 100mg/ml are presented in Table 
1. All the evaluated extracts demonstrated 
antimicrobial activity against the selected bacterial and 
fungal strains with inhibition zones greater than 7 mm 
(diameter of the well). The extracts that exhibited high 
antimicrobial activity (zone of inhibition ≥ 14 mm) were 
methanolic extracts of the aerial parts of F. africana 
against all the bacterial strains tested, ethylacetate 
extracts of F. africana aerial parts against Klebsiella 
pneumonia and ethylacetate extracts of P. lanceolata 
roots against all the tested bacterial stains. 
Methanolic extracts of F. africana aerial parts had the 
highest activity against Klebsiella pneumonia with a 
zone of inhibition measuring 17.21±0.22 mm, followed 
by ethylacetate extracts of P. lanceolata roots with a 
zone of inhibition of 17.06±0.28 mm. The antibacterial 
standard drug Gentamycin (0.10µg/ml) had a zone of 
inhibition of 23.88±0.01 mm.   
Generally, S. hildebrandtii extracts showed lower 
antimicrobial effects compared to the other plant 
extracts as none of the extracts produced a zone of 
inhibition more than 12 mm for all the tested 
microorganisms. 
The zones of inhibition produced by the tested extracts 
against Candida albicans ranged from 9.73±0.14 mm to 
12.41±0.35 mm. The widest zone of inhibition was 
produced by methanolic root extracts of P. lanceolata 
while methanolic root extract of S. hildebrandtii had the 
smallest zone of growth inhibition (Table 1). 
Table 1: Antimicrobial activitya of F. africana, P. lanceolata and S. hildebrandtii organic extracts at a concentration of 
100 mg/ml 
Plant species 
Plant 
part 
Test 
extracts 
Mean inhibition zone diameters (mm)±SEM 
Kp Ec Bs Bp Sa Ca 
F. africana  AP Methanol 17.21±0.22 14.24±0.35 15.35±0.63 15.4±0.41 15.18±0.42 11.62±0.74 
F. africana  AP Ethylacetate 14.55±0.46 13.17±0.2 13.9±0.72 12.16±0.44 13.09±0.28 10.62±0.62 
F. africana  R Methanol 13.10±0.26 10.4±0.74 11.64±0.65 11.45±0.68 12.09±0.64 11.77±0.31 
F. africana  R Ethylacetate 10.96±0.08 12.08±0.26 12.32±0.60 11.18±0.15 11.39±0.6 11.37±0.29 
P. lanceolata AP Methanol 9.15±0.18 9.63±0.11 9.30±0.08 9.70±0.12 9.43±0.05 10.73±0.43 
P. lanceolata R Methanol 11.49±0.11 10.6±0.07 10.55±0.13 11.06±0.06 10.40±0.05 12.41±0.35 
P. lanceolata AP Ethylacetate 10.32±0.06 9.44±0.32 9.84±0.07 9.94±0.09 9.89±0.01 10.33±0.41 
P. lanceolata R Ethylacetate 17.06±0.28 14.29±0.03 15.82±0.34 15.7±0.01 14.28±0.23 12.17±0.14 
S. hildebrandtii R Ethylacetate 11.28±0.09 10.33±0.06 11.18±0.20 11.58±0.28 10.66±0.18 11.30±0.30 
S. hildebrandtii AP Ethylacetate 9.64±0.05 9.66±0.18 10.08±0.09 10.20±0.05 9.78±0.02 11.35±0.20 
S. hildebrandtii R Methanol 10.38±0.08 9.98±0.06 9.85±0.05 9.34±0.05 10.16±0.09 9.73±0.14 
S. hildebrandtii AP Methanol 10.69±0.20 10.32±0.29 10.37±0.06 11.52±0.11 10.39±0.10 10.01±0.06 
Gentamycin     23.88±0.01 23.68±0.12 23.55±0.04 22.72±0.01 25.9±0.01 - 
Nystatin    - - - - - 22.21±0.02 
a Antibacterial activity depicted by the mean of inhibition zone diameter(mm) ± Standard Error of the Means (SEM) 
AP-Aerial Parts; R-Roots 
- Not done 
Kp-Klebsiella pneumonia, Ec-Escherichia coli, Bs-Bacillus subtilis, Bp-Bacillus pumillus, Sa- Staphylococcus aureus, Ca-Candida 
albicans 
 
 
 The MIC values of F. africana extracts are shown on 
Table 2. The lowest MIC value (0.39 mg/ml) was 
exhibited by ethylacetate extracts of the roots against 
all the tested micro-organisms as well as the methanolic 
extracts of the aerial parts against Candida albicans. 
 
Table 2 Minimum Inhibitory Concentrations (MIC) of F. 
africana extracts against selected bacteria and fungi 
Plant part Type of Extract 
MIC values (mg/ml) 
Sa Ec Ca 
Aerial parts Ethylacetate 1.56 1.56 3.125 
Aerial Parts Methanol 6.25 3.125 0.39 
Roots  Ethylacetate 0.39 0.39 0.39 
Roots Methanol 0.78 0.78 6.25 
Sa- Staphylococcus aureus, Ec-Escherichia coli, Ca-Candida 
albicans 
 
4.0 Discussion 
Ethnopharmacological reports indicate that the 
medicinal plants evaluated in this study are 
traditionally used to treat infections of microbial nature 
(TICHA 2008, Giday et al, 2009). The results obtained in 
this study partially support these claims as all the tested 
extracts demonstrated some antimicrobial effects.  
These findings demonstrate the potential of these plant 
species as sources of novel antimicrobial compounds, a 
potential supported by a recent study that showed that 
organic extracts of the three tested plant species had 
low cytotoxicity levels (CC50 > 20µg/ml) against Vero 
cell line (Kigondu et al, 2011).  An earlier study had also 
shown that organic extracts of F.  africana and P. 
lanceolata had low cyto-toxicity levels (CC50 > 20µg/ml) 
against cultured KB cells (Koch et al, 2005).  
There are no previous reports on antimicrobial effects 
of the three plant species investigated in this study. 
Nevertheless, previous pharmacological studies 
demonstrated in vitro antiplasmodial effects of F. 
africana (Koch et al, 2005; Muthaura et al, 2007; 
Muganga et al, 2010; Kigondu et al, 2011), P. lanceolata 
and S. hildebrandtii (Koch et al, 2005; Kigondu et al., 
2011). 
Phytochemical studies and isolation of bioactive 
compounds from the plants investigated have been 
limited. However, an antimalarial abietane diterpene, 
ferruginol, has been isolated from F. africana (Koch et 
al, 2006). In other studies, chemical investigation on the 
leaf of P. lanceolata revealed the presence of 
asperuloside, an iridoid monoterpene and a series of 
iridoid glucosides (Inouye et al, 1988; Schripsema et al, 
2007).  
There is therefore still a need to conduct detailed 
bioassay-guided phytochemical studies in the bid to 
identify and characterize bioactive secondary 
metabolites which can be used as templates for new 
drugs development programs or as markers for 
standardisation of antimicrobial herbal remedies. In 
particular, the high activities exhibited by F. africana 
and P. lanceolata extracts demonstrate the potential of 
these plants species as a source of novel, alternative 
antimicrobial agents. 
In conclusion, the results obtained in this study provide 
a partial rationale for the use of these medicinal plants 
in traditional medicines. Further studies to establish the 
safety profiles of the bioactive extracts in an animal 
model and identification of their chemical constituents 
which can be used as markers for standardization of 
antimicrobial herbal remedies are ongoing. 
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